Point of Care Diagnostics Market worth $31.46 billion by 2031
The report "Point of Care Diagnostics Market by Product (Glucose, Infectious Disease [TB, HAI, STD], Pregnancy), Purchase Mode (Rx, OTC), Technology (Biochemistry, MDx [RT-PCR, INAAT]), Sample (Blood, Urine), End User (Home Care, Hospitals) - Global Forecast to 2031" is projected to reach USD 31.46 billion by 2031 from USD 20.63 billion in 2026, growing at a CAGR of 8.8%.
Browse 250 market data Tables and 100 Figures spread through 300 Pages and in-depth TOC on "Point of Care Diagnostics Market, by Product (Glucose, Infectious Disease [TB, HAI, STD], Pregnancy), Purchase Mode (Rx, OTC), Technology (Biochemistry, MDx [RT-PCR, INAAT]), Sample (Blood, Urine), End User (Home Care, Hospitals) - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html
The growing prevalence of chronic and infectious diseases that require rapid diagnosis is driving the POC diagnostics market. Increasing incidences of diabetes, cardiovascular diseases, respiratory infections, and other acute and chronic conditions are fueling demand for fast and accurate diagnostic solutions at the point of care. POC diagnostic devices, including blood glucose monitors, rapid antigen and molecular tests, cardiac biomarker analyzers, pregnancy and fertility tests, and portable hematology and immunoassay systems, enable timely diagnosis and immediate clinical decision-making across hospitals, physicians' offices, emergency departments, pharmacies, and home care settings. The growing shift toward decentralized healthcare, supported by telemedicine and digital health technologies, is further accelerating market adoption. Additionally, rising demand for home-based testing, increasing emphasis on early disease detection and preventive healthcare, and continuous advancements in portable, AI-enabled, and connected diagnostic technologies continue to strengthen demand for point-of-care diagnostic solutions globally.
Glucose monitoring products accounted for the largest share of the global point-of-care diagnostics market in 2025.
The segment's dominance is primarily driven by the high global burden of diabetes, which requires regular blood glucose monitoring across hospitals, clinics, diagnostic centers, pharmacies, and home-care settings. The increasing adoption of point-of-care blood glucose meters and continuous glucose monitoring (CGM)-enabled testing solutions supports rapid clinical decision-making, effective glycemic management, and improved patient outcomes. Growing awareness of diabetes prevention and self-management, coupled with the expanding aging population and rising incidence of lifestyle-related diseases, continues to boost demand for glucose monitoring products. In addition, technological advancements, including smartphone-connected glucose meters, improved biosensor accuracy, cloud-based data integration, and minimally invasive monitoring technologies, are enhancing testing convenience and accuracy. Favorable reimbursement policies, continuous product innovation, and expanding diabetes screening and management programs across developed and emerging markets further strengthen the segment's leading position, enabling glucose monitoring products to maintain the highest market value among all point-of-care diagnostics product categories in 2025.
Clinical laboratories accounted for the largest share of the global point-of-care diagnostics market in 2025.
The dominance of clinical laboratories is driven by their central role in delivering high-volume diagnostic testing with rapid and reliable results across a broad range of diseases. Clinical laboratories are widely used for point-of-care testing for infectious diseases, glucose monitoring, cardiometabolic disorders, coagulation, and other routine diagnostic applications, making them the primary end users of point-of-care diagnostic products. The growing prevalence of chronic and infectious diseases, increasing demand for early disease detection, and rising diagnostic testing volumes continue to support market growth. Furthermore, the expansion of laboratory networks, improvements in automated and portable diagnostic technologies, and greater integration of digital data management systems have enhanced testing efficiency and turnaround times. Increasing investments in healthcare infrastructure, expanding access to diagnostic services, and the growing emphasis on preventive healthcare and routine screening further reinforce the leading position of clinical laboratories, enabling them to maintain the highest market share in the global point-of-care diagnostics market in 2025.
Asia Pacific set to witness robust growth through 2031.
The Asia Pacific is projected to register the highest growth in the global point-of-care diagnostics market, driven by the region's large and aging population, increasing prevalence of chronic and infectious diseases, and rising demand for rapid, accurate diagnostic testing. Additionally, improvements in healthcare infrastructure, increased healthcare spending, supportive government initiatives, and expanded access to primary healthcare are accelerating the adoption of point-of-care diagnostic solutions. The growing shift toward decentralized healthcare, including home-based testing and community care, along with ongoing advancements in portable, user-friendly diagnostic technologies, is expected to further drive market growth across the region.
Key Market Players:
Key players in this market are adopting various organic and inorganic growth strategies, including product launches, agreements, collaborations, acquisitions, and expansions. Prominent players in the global point-of-care diagnostics market include Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Siemens Healthineers AG (Germany), QuidelOrtho Corporation (US), bioMérieux SA (France), Werfen S.A. (Spain), Becton, Dickinson and Company (US), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific Inc. (US), OraSure Technologies, Inc. (US), EKE Diagnostics (China), Trinity Biotech plc (Ireland), Grifols S.A. (Spain), Nova Biomedical Corporation (US), Sekisui Diagnostics, LLC (US), Trividia Health, Inc. (US), Sysmex Corporation (Japan), HemoCue AB (Sweden), and Bio-Rad Laboratories, Inc. (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Point of Care Diagnostics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
